BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/8/2021 10:51:03 AM | Browse: 782 | Download: 1703
 |
Received |
|
2021-02-09 16:17 |
|
Peer-Review Started |
|
2021-02-04 15:23 |
|
First Decision by Editorial Office Director |
|
2021-03-28 22:33 |
|
Return for Revision |
|
2021-03-28 22:33 |
|
Revised |
|
2021-04-09 07:16 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-05-07 08:04 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-05-07 12:00 |
|
Articles in Press |
|
2021-05-07 12:00 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-06-02 03:24 |
|
Publish the Manuscript Online |
|
2021-06-08 10:51 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Alessandro Granito, Luigi Muratori, Claudine Lalanne, Chiara Quarneti, Silvia Ferri, Marcello Guidi, Marco Lenzi and Paolo Muratori |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alessandro Granito, MD, Assistant Professor, Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Via Albertoni 15, Bologna 40138, Italy. alessandro.granito@unibo.it |
| Key Words |
Autoimmune liver disease; Hepatitis B virus-related chronic hepatitis; Hepatitis C virus-related chronic hepatitis; Hepatocellular carcinoma; Tumor microenvironment |
| Core Tip |
Hepatocellular carcinoma (HCC) is the fifth most common cancer with poor prognosis despite significant improved diagnostic and therapeutic strategies. Most of HCC occurs in cirrhotic patients, with hepatitis B and C viruses being leading causes, Recent studies showed that HCC development and progression are associated with a unique immune response profile of the liver microenvironment where CD4+CD25+ Foxp3 regulatory T-cells (Tregs) play a crucial role through their immunosuppressive role. We discuss the role of Tregs in chronic liver diseases as well as in HCC initiation and the role of immunotherapy to enhance anti-tumor immune response by blocking Treg activity. |
| Publish Date |
2021-06-08 10:51 |
| Citation |
Granito A, Muratori L, Lalanne C, Quarneti C, Ferri S, Guidi M, Lenzi M, Muratori P. Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment. World J Gastroenterol 2021; 27(22): 2994-3009 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i22/2994.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i22.2994 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
